174 related articles for article (PubMed ID: 34047410)
1. Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint.
Schnitzler A; Mir P; Brodsky MA; Verhagen L; Groppa S; Alvarez R; Evans A; Blazquez M; Nagel S; Pilitsis JG; Pötter-Nerger M; Tse W; Almeida L; Tomycz N; Jimenez-Shahed J; Libionka W; Carrillo F; Hartmann CJ; Groiss SJ; Glaser M; Defresne F; Karst E; Cheeran B; Vesper J;
Neuromodulation; 2022 Aug; 25(6):817-828. PubMed ID: 34047410
[TBL] [Abstract][Full Text] [Related]
2. Directional versus ring-mode deep brain stimulation for Parkinson's disease: protocol of a multi-centre double-blind randomised crossover trial.
Brinke TRT; Jergas H; Sisodia V; Barbe MT; Odekerken VJJ; Verbaan D; Dijk JM; Bot M; Beudel M; van den Munckhof P; Schuurman PR; de Bie RMA
BMC Neurol; 2023 Oct; 23(1):372. PubMed ID: 37853327
[TBL] [Abstract][Full Text] [Related]
3. Automated deep brain stimulation programming based on electrode location: a randomised, crossover trial using a data-driven algorithm.
Roediger J; Dembek TA; Achtzehn J; Busch JL; Krämer AP; Faust K; Schneider GH; Krause P; Horn A; Kühn AA
Lancet Digit Health; 2023 Feb; 5(2):e59-e70. PubMed ID: 36528541
[TBL] [Abstract][Full Text] [Related]
4. Directional deep brain stimulation: an intraoperative double-blind pilot study.
Pollo C; Kaelin-Lang A; Oertel MF; Stieglitz L; Taub E; Fuhr P; Lozano AM; Raabe A; Schüpbach M
Brain; 2014 Jul; 137(Pt 7):2015-26. PubMed ID: 24844728
[TBL] [Abstract][Full Text] [Related]
5. Antiparkinsonian Drug Reduction After Directional Versus Omnidirectional Bilateral Subthalamic Deep Brain Stimulation.
Pintér D; Járdaházi E; Balás I; Harmat M; Makó T; Juhász A; Janszky J; Kovács N
Neuromodulation; 2023 Feb; 26(2):374-381. PubMed ID: 35190245
[TBL] [Abstract][Full Text] [Related]
6. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
8. Closed-loop programming using external responses for deep brain stimulation in Parkinson's disease.
Sasaki F; Oyama G; Sekimoto S; Nuermaimaiti M; Iwamuro H; Shimo Y; Umemura A; Hattori N
Parkinsonism Relat Disord; 2021 Mar; 84():47-51. PubMed ID: 33556765
[TBL] [Abstract][Full Text] [Related]
9. Directional Deep Brain Stimulation-A Step in the Right Direction? A Systematic Review of the Clinical and Therapeutic Efficacy of Directional Deep Brain Stimulation in Parkinson Disease.
Ramanathan PV; Salas-Vega S; Shenai MB
World Neurosurg; 2023 Feb; 170():54-63.e1. PubMed ID: 36435384
[TBL] [Abstract][Full Text] [Related]
10. Directional DBS increases side-effect thresholds-A prospective, double-blind trial.
Dembek TA; Reker P; Visser-Vandewalle V; Wirths J; Treuer H; Klehr M; Roediger J; Dafsari HS; Barbe MT; Timmermann L
Mov Disord; 2017 Oct; 32(10):1380-1388. PubMed ID: 28843009
[TBL] [Abstract][Full Text] [Related]
11. Asleep Surgery May Improve the Therapeutic Window for Deep Brain Stimulation of the Subthalamic Nucleus.
Senemmar F; Hartmann CJ; Slotty PJ; Vesper J; Schnitzler A; Groiss SJ
Neuromodulation; 2021 Feb; 24(2):279-285. PubMed ID: 32662156
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
13. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
15. CLOVER-DBS: Algorithm-Guided Deep Brain Stimulation-Programming Based on External Sensor Feedback Evaluated in a Prospective, Randomized, Crossover, Double-Blind, Two-Center Study.
Wenzel GR; Roediger J; Brücke C; Marcelino ALA; Gülke E; Pötter-Nerger M; Scholtes H; Wynants K; Juárez Paz LM; Kühn AA
J Parkinsons Dis; 2021; 11(4):1887-1899. PubMed ID: 34151855
[TBL] [Abstract][Full Text] [Related]
16. Directional Stimulation in Parkinson's Disease and Essential Tremor: The Cleveland Clinic Experience.
Rammo RA; Ozinga SJ; White A; Nagel SJ; Machado AG; Pallavaram S; Cheeran BJ; Walter BL
Neuromodulation; 2022 Aug; 25(6):829-835. PubMed ID: 33733515
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
19. King's Parkinson's Disease Pain Scale for Assessment of Pain Relief Following Deep Brain Stimulation for Parkinson's Disease.
DiMarzio M; Pilitsis JG; Gee L; Peng S; Prusik J; Durphy J; Ramirez-Zamora A; Hanspal E; Molho E; McCallum SE
Neuromodulation; 2018 Aug; 21(6):617-622. PubMed ID: 29608802
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Clinical Experience with Directional Deep Brain Stimulation Programming: A Retrospective Review.
Karl JA; Joyce J; Ouyang B; Verhagen Metman L
Neurol Ther; 2022 Sep; 11(3):1309-1318. PubMed ID: 35776383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
